180 related articles for article (PubMed ID: 26697546)
21. Overview and treatment of opioid-induced constipation.
McCarberg BH
Postgrad Med; 2013 Jul; 125(4):7-17. PubMed ID: 23782897
[No Abstract] [Full Text] [Related]
22. Methylnaltrexone in palliative care: further research is needed.
Clark K; Currow DC
J Pain Symptom Manage; 2014 Feb; 47(2):e5-6. PubMed ID: 24411184
[No Abstract] [Full Text] [Related]
23. Treating Opioid-Induced Constipation in Older Adults: New Options.
Sani H; Mahan RJ
Consult Pharm; 2015 Oct; 30(10):612-5. PubMed ID: 26450143
[TBL] [Abstract][Full Text] [Related]
24. [Opioid-induced bowel dysfunction: a literature analysis on pathophysiology and treatment].
Osterbrink J; Haas U
Wien Med Wochenschr; 2008; 158(21-22):621-6. PubMed ID: 19052708
[TBL] [Abstract][Full Text] [Related]
25. Opioid-Related Constipation.
Liu JJ; Brenner DM
Gastroenterol Clin North Am; 2022 Mar; 51(1):107-121. PubMed ID: 35135657
[TBL] [Abstract][Full Text] [Related]
26. Methylnaltrexone: treatment for opioid-induced constipation--not convinced yet.
HaiNan Liu ; Xiulu Ruan
Am J Hosp Palliat Care; 2011 Jun; 28(4):290; author reply 291. PubMed ID: 21454318
[No Abstract] [Full Text] [Related]
27. Naloxegol (Movantik) for opioid-induced constipation.
Med Lett Drugs Ther; 2015 Sep; 57(1478):135-7. PubMed ID: 26393826
[No Abstract] [Full Text] [Related]
28. Opioid-Induced Constipation Part 2: Newer Therapies #295.
Badke A; Rosielle DA
J Palliat Med; 2015 Oct; 18(10):893-4. PubMed ID: 26439728
[No Abstract] [Full Text] [Related]
29. Pharmacological Treatment of Opioid-Induced Constipation Is Effective but Choice of Endpoints Affects the Therapeutic Gain.
Nusrat S; Syed T; Saleem R; Clifton S; Bielefeldt K
Dig Dis Sci; 2019 Jan; 64(1):39-49. PubMed ID: 30284134
[TBL] [Abstract][Full Text] [Related]
30. ▼Naloxegol for opioid-induced constipation.
Drug Ther Bull; 2015 Dec; 53(12):138-40. PubMed ID: 26660436
[TBL] [Abstract][Full Text] [Related]
31. Managing opioid-induced constipation.
Nursing; 2008 Jul; 38(7):55. PubMed ID: 18580669
[No Abstract] [Full Text] [Related]
32. Naloxegol: a review of its use in patients with opioid-induced constipation.
Garnock-Jones KP
Drugs; 2015 Mar; 75(4):419-25. PubMed ID: 25666542
[TBL] [Abstract][Full Text] [Related]
33. Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approach.
Reimer K; Hopp M; Zenz M; Maier C; Holzer P; Mikus G; Bosse B; Smith K; Buschmann-Kramm C; Leyendecker P
Pharmacology; 2009; 83(1):10-7. PubMed ID: 18957874
[TBL] [Abstract][Full Text] [Related]
34. [Survey of Prophylactic Administration of Naldemedine for Opioid-induced Constipation].
Ozawa Y; Haruki Y; Ohata M; Isono H; Takahashi M; Tate A; Ukita S; Hayashi S
Yakugaku Zasshi; 2023; 143(2):183-189. PubMed ID: 36724931
[TBL] [Abstract][Full Text] [Related]
35. [Constipation as an adverse drug reaction].
Kopf A
Pharm Unserer Zeit; 2008; 37(2):162-6. PubMed ID: 18293325
[No Abstract] [Full Text] [Related]
36. Peripheral opioid antagonists: a therapeutic advance for optimizing opioid gastrointestinal tolerability.
Fakata KL; Cole BE
J Fam Pract; 2007 Jun; 56(6 Suppl Peripheral):S3-12. PubMed ID: 17543252
[No Abstract] [Full Text] [Related]
37. Naloxegol: treatment for opioid-induced constipation in chronic non-cancer pain.
Leonard J; Baker DE
Ann Pharmacother; 2015 Mar; 49(3):360-5. PubMed ID: 25471070
[TBL] [Abstract][Full Text] [Related]
38. Laxative utilization over time in chronic pain patients with opioid-induced constipation.
Datto CJ; LoCasale RJ; Margolis MK; Thompson CL; Coyne KS
Pain Manag; 2016 Nov; 6(6):531-541. PubMed ID: 27476539
[TBL] [Abstract][Full Text] [Related]
39. [Opiate induced constipation--mechanisms, relevance and treatment].
Müller-Lissner S
Dtsch Med Wochenschr; 2013 Oct; 138(43):2207-11. PubMed ID: 24132534
[No Abstract] [Full Text] [Related]
40. Naldemedine (Symproic) for opioid-induced constipation.
Med Lett Drugs Ther; 2017 Dec; 59(1535):196-198. PubMed ID: 29186083
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
